Search

Your search keyword '"Rostrup, Morten"' showing total 316 results

Search Constraints

Start Over You searched for: Author "Rostrup, Morten" Remove constraint Author: "Rostrup, Morten"
316 results on '"Rostrup, Morten"'

Search Results

1. Effect of Therapeutic Drug Monitoring on Adherence and Blood Pressure: A Multicenter Randomized Clinical Trial.

2. Effect of Drug Monitoring on Adherence and Blood Pressure: A Multicenter Randomized Clinical Trial

3. ACHIEVED SYSTOLIC BLOOD PRESSURE BELOW 130 MMHG PRESERVES KIDNEY FUNCTION IN DIABETIC AND NON-DIABETIC HYPERTENSIVE PATIENTS WITHOUT CARDIAC HYPERTROPHY

4. ACHIEVED SYSTOLIC BLOOD PRESSURE BELOW 130 MMHG PRESERVES KIDNEY FUNCTION IN HIGH-RISK HYPERTENSIVE PATIENTS WITHOUT CARDIAC HYPERTROPHY BUT WITH PROTEINURIA

5. ASSESSMENT OF THE NORRISK 2 AND THE SCORE2-DIABETES RISK ALGORITHMS IN PATIENTS WITH HYPERTENSION – ROOM FOR IMPROVEMENTS

6. TEN YEAR FOLLOW-UP OF PATIENTS WITH RESISTANT HYPERTENSION RANDOMIZED TO RENAL DENERVATION OR ANTIHYPERTENSIVE DRUG TREATMENT

7. CARDIAC TROPONIN-T AND N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE RELATED TO OTHER CLINICAL HIGH-RISK FACTORS IN PATIENTS ON AT LEAST TWO ANTIHYPERTENSIVE AGENTS

11. Middle-Aged and Older Patients With Left Ventricular Hypertrophy: Higher Mortality With Drug Treated Systolic Blood Pressure Below 130 mm Hg

12. SHOULD MIDDLE-AGED AND OLDER HIGH-RISK HYPERTENSIVE PATIENTS WITH DIABETES BE TREATED TO TARGET BT <130/80 MMHG?

16. Nonadherence by Serum Drug Analyses in Resistant Hypertension: 7‐Year Follow‐Up of Patients Considered Adherent by Directly Observed Therapy

17. IMPLICATIONS OF CYP2D6 POLYMORPHISMS FOR THERAPEUTIC DRUG MONITORING IN PATIENTS WITH HYPERTENSION

19. Bearing witness

21. Detection of Nonadherence to Antihypertensive Treatment by Measurements of Serum Drug Concentrations

23. Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus compared to all middle-aged and elderly hypertensive study patients with high cardiovascular risk

26. PHYSICIAN- AND PATIENT REPORTED ADHERENCE TO ANTIHYPERTENSIVE DRUGS VERIFIED BY SERUM DRUG CONCENTRATION

27. CARDIOVASCULAR OUTCOMES AT RECOMMENDED BLOOD PRESSURE TARGETS IN MIDDLE AGED AND ELDERLY PATIENTS WITH TYPE 2 DIABETES MELLITUS AND HYPERTENSION

29. Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus compared to all middle-aged and elderly hypertensive study patients with high cardiovascular risk

31. High altitude affects the heart

33. T.M. Gundem og medarbeidere svarer

34. Ventilasjonsstøtte for hypoksemiske intensivpasienter med covid-19

35. Blood pressure variability in hypertensive patients with atrial fibrillation in the VALUE trial

36. Prehypertension and Cardiometabolic Syndrome

46. Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus and hypertension.

47. A 20-year prospective study of mortality and causes of death among hospitalized opioid addicts in Oslo

48. Personality may influence reactivity to stress

50. Renal sympathetic denervation lowers systemic vascular resistance in true treatment-resistant hypertension.

Catalog

Books, media, physical & digital resources